Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH.

"CONFLICTS OF INTEREST Kyle J. Kalutkiewicz is employed by and consults for Resoundant, Inc. Kevin J. Glaser owns stock in and intellectual property rights with Resoundant, Inc. Armando Manduca owns stock in Resoundant, Inc. Richard L. Ehman owns stock in, owns intellectual property rights with, and received grants from Resoundant, Inc. Alina M. Allen consults for, advises, and received grants from Novo Nordisk. She received grants from Pfizer and Target Pharma. Meng Yin owns stock in and intellectual property rights with Resoundant, Inc. The remaining authors have no conflicts to report."

"FUNDING INFORMATION This work has been supported by grant funding from the National Institutes of Health (K23 DK115594, P30 DK084567, R01 AA021171, R37 EB001981, R01 EB017197), the US Department of Defense (W81XWH-19-1-0583-01), and the Mayo Clinic."